Verition Fund Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $773K | Sell |
6,119
-590
| -9% | -$77.7K | ﹤0.01% | 1516 |
|
|
2026
Q1 | $935K | Sell |
6,709
-61,468
| -90% | -$8.61M | 0.01% | 1334 |
|
|
2025
Q4 | $8.37M | Sell |
68,177
-667
| -1% | -$81.1K | 0.03% | 551 |
|
|
2025
Q3 | $7.64M | Buy |
68,844
+44,757
| +186% | +$5.09M | 0.03% | 724 |
|
|
2025
Q2 | $2.67M | Sell |
24,087
-272,388
| -92% | -$29M | 0.01% | 1707 |
|
|
2025
Q1 | $33.2M | Buy |
296,475
+161,666
| +120% | +$16.7M | 0.15% | 98 |
|
|
2024
Q4 | $12.5M | Buy |
134,809
+93,663
| +228% | +$8.43M | 0.05% | 425 |
|
|
2024
Q3 | $3.45M | Sell |
41,146
-60,372
| -59% | -$4.61M | 0.02% | 1087 |
|
|
2024
Q2 | $6.97M | Buy |
101,518
+34,101
| +51% | +$2.28M | 0.04% | 529 |
|
|
2024
Q1 | $4.94M | Buy |
67,417
+20,225
| +43% | +$1.56M | 0.03% | 686 |
|
|
2023
Q4 | $3.82M | Buy |
47,192
+9,062
| +24% | +$705K | 0.03% | 541 |
|
|
2023
Q3 | $2.86M | Buy |
+38,130
| New | +$2.93M | 0.03% | 649 |
|
|
2023
Q1 | – | Sell |
-10,608
| Closed | -$911K | – | 2300 |
|
|
2022
Q4 | $911K | Sell |
10,608
-37,413
| -78% | -$2.96M | 0.01% | 956 |
|
|
2022
Q3 | $2.96M | Buy |
48,021
+19,171
| +66% | +$1.21M | 0.03% | 682 |
|
|
2022
Q2 | $1.78M | Sell |
28,850
-20,292
| -41% | -$1.26M | 0.04% | 728 |
|
|
2022
Q1 | $2.92M | Buy |
49,142
+25,149
| +105% | +$1.61M | 0.04% | 707 |
|
|
2021
Q4 | $1.74M | Buy |
+23,993
| New | +$1.65M | 0.01% | 969 |
|
|
2021
Q2 | – | Sell |
-122,516
| Closed | -$7.92M | – | 1983 |
|
|
2021
Q1 | $7.92M | Buy |
122,516
+115,611
| +1,674% | +$7.45M | 0.09% | 137 |
|
|
2020
Q4 | $402K | Buy |
+6,905
| New | +$417K | ﹤0.01% | 728 |
|
|
2020
Q3 | – | Sell |
-48,277
| Closed | -$3.71M | – | 1185 |
|
|
2020
Q2 | $3.71M | Buy |
+48,277
| New | +$3.7M | 0.12% | 137 |
|
|
2020
Q1 | – | Sell |
-60,381
| Closed | -$4.17M | – | 777 |
|
|
2019
Q4 | $3.92M | Buy |
60,381
+17,399
| +40% | +$1.13M | 0.07% | 174 |
|
|
2019
Q3 | $2.72M | Sell |
42,982
-29,664
| -41% | -$1.94M | 0.08% | 174 |
|
|
2019
Q2 | $4.91M | Buy |
72,646
+25,597
| +54% | +$1.68M | 0.14% | 114 |
|
|
2019
Q1 | $3.06M | Sell |
47,049
-26,902
| -36% | -$1.79M | 0.12% | 122 |
|
|
2018
Q4 | $4.63M | Buy |
73,951
+4,244
| +6% | +$297K | 0.33% | 63 |
|
|
2018
Q3 | $5.38M | Buy |
69,707
+33,504
| +93% | +$2.53M | 0.19% | 85 |
|
|
2018
Q2 | $2.56M | Buy |
36,203
+27,846
| +333% | +$1.97M | 0.16% | 136 |
|
|
2018
Q1 | $630K | Sell |
8,357
-15,835
| -65% | -$1.26M | 0.05% | 546 |
|
|
2017
Q4 | $1.73M | Buy |
24,192
+16,548
| +216% | +$1.26M | 0.16% | 125 |
|
|
2017
Q3 | $619K | Buy |
+7,644
| New | +$585K | 0.05% | 479 |
|
|
2017
Q1 | – | Sell |
-26,495
| Closed | -$1.9M | – | 1280 |
|
|
2016
Q4 | $1.9M | Buy |
+26,495
| New | +$1.97M | 0.16% | 120 |
|
|
2016
Q3 | – | Sell |
-5,112
| Closed | -$426K | – | 1200 |
|
|
2016
Q2 | $426K | Buy |
5,112
+291
| +6% | +$25.8K | 0.05% | 453 |
|
|
2016
Q1 | $443K | Sell |
4,821
-4,441
| -48% | -$400K | 0.07% | 357 |
|
|
2015
Q4 | $937K | Buy |
9,262
+6,066
| +190% | +$631K | 0.18% | 112 |
|
|
2015
Q3 | $314K | Buy |
+3,196
| New | +$355K | 0.08% | 329 |
|
|
2014
Q4 | – | Sell |
-5,538
| Closed | -$590K | – | 467 |
|
|
2014
Q3 | $590K | Buy |
+5,538
| New | +$542K | 0.08% | 202 |
|
|
2014
Q2 | – | Sell |
-3,619
| Closed | -$256K | – | 703 |
|
|
2014
Q1 | $256K | Buy |
3,619
+521
| +17% | +$40.9K | 0.04% | 317 |
|
|
2013
Q4 | $233K | Sell |
3,098
-9,988
| -76% | -$695K | 0.04% | 346 |
|
|
2013
Q3 | $822K | Buy |
+13,086
| New | +$782K | 0.12% | 135 |
|
Other funds holding GILD
Verition Fund Management's GILD Position: Q2 2026 in Review
Verition Fund Management reduced its Gilead Sciences (GILD) stake by 8.8% in Q2 2026, selling an estimated $77.7K and leaving 6,119 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #1516.
Verition Fund Management first reported a position in GILD in Q3 2013 and has held it in 39 quarters since. The position peaked at $33.2M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Verition Fund Management held 6,119 shares of Gilead Sciences worth $773K as of Q2 2026.
- Verition Fund Management sold 590 Gilead Sciences shares in Q2 2026, an estimated $77.7K.
- Gilead Sciences made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1516 holding.
- Verition Fund Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 39 quarters since.
- Verition Fund Management's Gilead Sciences position peaked at $33.2M in Q1 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.